KaloCyte Inc
Baltimore, MD · Founded 2016 · CIK 0001738542 · Biotech · Private
ErythroMer™, a dried bio-inspired artificial red blood cell for transfusion
kalocyte.com →- Grants
- $9.0M
- 11 awards
- Sector median: 1
- Raised
- $800K
- 1 Form D · May 2018
- 101 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 6
- 1 granted · 5 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · ErythroMer: Nanoscale Bio-Synthetic Red Cell Substitute | $397,622 | |
| Private capital raised | Form D · SEC | $800,000 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · ErythroMer: Nanoscale Bio-Synthetic Red Cell Substitute | $1,622,208 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · ErythroMer: Nanoscale Bio-Synthetic Red Cell Substitute | $833,728 | |
| Federal grant | Department of Health and Human Services · Phase II · ErythroMer: Nanoscale Bio-Synthetic Red Cell Substitute | $788,480 | |
| Federal grant | Department of Health and Human Services · Phase I · Rapid Reconstitution of a Lyophilized, Bio-inspired, Artificial Red Blood Cell | $373,216 | |
| Federal grant | Department of Health and Human Services · Phase I · Rapid Reconstitution of a Lyophilized, Bio-inspired, Artificial Red Blood Cell | $373,216 | |
| Federal grant | Department of Health and Human Services · Phase II · Manufacturing Scale-up, Purification, and Analytical Method Development, Validation and Qualification for KC1003, Key Precursor for ErythroMer (RBC substitute) | $499,999 | |
| Federal grant | Department of Health and Human Services · Phase II · ErythroMer: Nanoscale BioSynthetic Red Cell Substitute | $1,050,000 | |
| Federal grant | Department of Health and Human Services · Phase II · ErythroMer: Nanoscale BioSynthetic Red Cell Substitute | $1,050,000 | |
| Federal grant | Department of Health and Human Services · Phase II · ErythroMer: Nanoscale BioSynthetic Red Cell Substitute | $997,590 | |
| Federal grant | Department of Health and Human Services · Phase II · ErythroMer: Nanoscale BioSynthetic Red Cell Substitute | $995,470 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2579 | Chemistry Holdings, Inc. | — | $845K |
| 2580 | SOUTHEAST TECHINVENTURES, INC. | — | $836K |
| 2581 | RAPHAEL PHARMACEUTICALS LLC | — | — |
| 2582 | KaloCyte Inc | — | $800K |
| 2583 | Metagenomi | — | — |
| 2584 | PRAETEGO, INC. | — | $783K |
| 2585 | Indigo Biosciences Inc. | — | $782K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Allan DoctorDirector · Executive Officer
- Daniel GetmanDirector
- Gregory LanzaDirector
- Dipanjan PanDirector
- Philip SpinellaDirector
Patents
- Self-assembling Oxygen Carrier Compositionsgranted
- Composition And Process For A Lipid Nano-particle Delivery Of Oxygen And Vital Metabolic Compounds For Hemorrhagic Shockapplication
- Composition And Process For A Lipid Nano-particle Delivery Of Oxygen And Vital Metabolic Compounds For Hemorrhagic Shockapplication
- Self-assembling Oxygen Carrier Compositionsapplication
- Compositions And Methods For Removing Bio-synthetic Nano-particles From Bodily Fluidsapplication
- Self-assembling Oxygen Carrier Compositionsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.